Abstract
Microglial cells are extremely important for homeostasis of the CNS. Upon brain damage, microglia become reactive in response to inflammatory stimuli and lead to the secretion of inflammatory cytokines. Because microglia have the ability of adjusting their steady state to an active phenotype that modulates the CNS environment, chronic activation of microglia has an important role in mediating neuroinflammatory brain diseases. Depending upon the nature and degree of the injury stimulus, microglial activity may alternate, either to acute and mild responses -sometimes beneficial- or chronic and severe that may result in neurodegeneration. In this context, proper and controlled activation of microglia should be considered as a potential neuroprotective strategy against neurodegeneration. More recently, the use of estrogenic compounds to regulate microgliosis has shown promising results, and is currently being investigated due to their potential pharmacologic ability in the regulation of inflammation. In this review, we highlight the role of microgliamediated damage and discuss the effect of neurosteroids in reducing the adverse impact of inflammation in the brain.
Keywords: Neurosteroids, microglia, neuroinflammation, brain damage, neuroprotection, neurodegeneration.
CNS & Neurological Disorders - Drug Targets
Title:Microglial dependent protective effects of neuroactive steroids
Volume: 15 Issue: 2
Author(s): Oscar Hidalgo Lanussa, Marco Ávila-Rodriguez, Luis Miguel García-Segura, Janneth González, Valentina Echeverria, Gjumrakch Aliev and George E. Barreto
Affiliation:
Keywords: Neurosteroids, microglia, neuroinflammation, brain damage, neuroprotection, neurodegeneration.
Abstract: Microglial cells are extremely important for homeostasis of the CNS. Upon brain damage, microglia become reactive in response to inflammatory stimuli and lead to the secretion of inflammatory cytokines. Because microglia have the ability of adjusting their steady state to an active phenotype that modulates the CNS environment, chronic activation of microglia has an important role in mediating neuroinflammatory brain diseases. Depending upon the nature and degree of the injury stimulus, microglial activity may alternate, either to acute and mild responses -sometimes beneficial- or chronic and severe that may result in neurodegeneration. In this context, proper and controlled activation of microglia should be considered as a potential neuroprotective strategy against neurodegeneration. More recently, the use of estrogenic compounds to regulate microgliosis has shown promising results, and is currently being investigated due to their potential pharmacologic ability in the regulation of inflammation. In this review, we highlight the role of microgliamediated damage and discuss the effect of neurosteroids in reducing the adverse impact of inflammation in the brain.
Export Options
About this article
Cite this article as:
Lanussa Hidalgo Oscar, Ávila-Rodriguez Marco, García-Segura Miguel Luis, González Janneth, Echeverria Valentina, Aliev Gjumrakch and Barreto E. George, Microglial dependent protective effects of neuroactive steroids, CNS & Neurological Disorders - Drug Targets 2016; 15 (2) . https://dx.doi.org/10.2174/1871527315666160202122032
DOI https://dx.doi.org/10.2174/1871527315666160202122032 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pyrimidine Salvage Pathway in Mycobacterium tuberculosis
Current Medicinal Chemistry Stem Cells and Nanoparticles in Therapy
Nanoscience & Nanotechnology-Asia The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design Physiologically-based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-drug Interactions
Current Drug Metabolism The Cardiac hERG/IKr Potassium Channel as Pharmacological Target: Structure, Function, Regulation, and Clinical Applications
Current Pharmaceutical Design Gene Delivery for Periodontal Tissue Engineering: Current Knowledge – Future Possibilities
Current Gene Therapy Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects
CNS & Neurological Disorders - Drug Targets Pharmacogenetic Syndrome of Dihydropyrimidine Dehydrogenase Deficiency
Current Pharmacogenomics Antivirals Used for Influenza Chemoprophylaxis
Current Medicinal Chemistry Circadian Rhythm in Cytokines Administration
Mini-Reviews in Medicinal Chemistry Vincristine-Induced Seizure Potentiated by Itraconazole Following RCHOP Chemotherapy for Diffuse Large B-Cell Lymphoma
Current Drug Safety The Production of Solid Dosage Forms from Non-Degradable Polymers
Current Pharmaceutical Design Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Current Medicinal Chemistry Editorial (Thematic Issue: New Behaviors, New Drugs: The Modern Landscape of Addiction)
Current Pharmaceutical Design Assessing the Effectiveness of a Telemedicine Initiative in Clinical Management of Children Living with HIV/AIDS in Maharashtra, India
Current HIV Research Antifungal Prophylaxis in the Neonatal Intensive Care Unit (NICU)
Current Pediatric Reviews Cardio-Hepatic Metabolic Derangements and Valproic Acid
Current Clinical Pharmacology Herpes Simplex Encephalitis: From Virus to Therapy
Infectious Disorders - Drug Targets Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment
Current Cancer Drug Targets Biomedical Applications of Poly(Lactic Acid)
Recent Patents on Regenerative Medicine